These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 10355397)

  • 1. Epsilon-aminocaproic acid administration and stroke following coronary artery bypass graft surgery.
    Bennett-Guerrero E; Spillane WF; White WD; Muhlbaier LH; Gall SA; Smith PK; Newman MF
    Ann Thorac Surg; 1999 May; 67(5):1283-7. PubMed ID: 10355397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind, placebo-controlled trial of epsilon-aminocaproic acid for reducing blood loss in coronary artery bypass grafting surgery.
    Kikura M; Levy JH; Tanaka KA; Ramsay JG
    J Am Coll Surg; 2006 Feb; 202(2):216-22; quiz A44-5. PubMed ID: 16427545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epsilon-aminocaproic acid in coronary artery bypass graft surgery: preincision or postheparin?
    Kluger R; Olive DJ; Stewart AB; Blyth CM
    Anesthesiology; 2003 Dec; 99(6):1263-9. PubMed ID: 14639137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of prophylactic epsilon-aminocaproic acid on blood loss and transfusion requirements in patients undergoing first-time coronary artery bypass grafting. A randomized, prospective, double-blind study.
    Daily PO; Lamphere JA; Dembitsky WP; Adamson RM; Dans NF
    J Thorac Cardiovasc Surg; 1994 Jul; 108(1):99-106; discussion 106-8. PubMed ID: 8028387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraoperative antifibrinolysis and blood-saving techniques in cardiac surgery. Prospective trial of 3 antifibrinolytic drugs.
    Penta de Peppo A; Pierri MD; Scafuri A; De Paulis R; Colantuono G; Caprara E; Tomai F; Chiariello L
    Tex Heart Inst J; 1995; 22(3):231-6. PubMed ID: 7580360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of prophylactic epsilon-aminocaproic acid on bleeding, transfusions, platelet function, and fibrinolysis during coronary artery bypass grafting.
    Troianos CA; Sypula RW; Lucas DM; D'Amico F; Mathie TB; Desai M; Pasqual RT; Pellegrini RV; Newfeld ML
    Anesthesiology; 1999 Aug; 91(2):430-5. PubMed ID: 10443606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seizures after open heart surgery: comparison of ε-aminocaproic acid and tranexamic acid.
    Martin K; Knorr J; Breuer T; Gertler R; Macguill M; Lange R; Tassani P; Wiesner G
    J Cardiothorac Vasc Anesth; 2011 Feb; 25(1):20-5. PubMed ID: 21272777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association of epsilon-aminocaproic acid with postoperative decrease in creatinine clearance in 1502 coronary bypass patients.
    Stafford-Smith M; Phillips-Bute B; Reddan DN; Black J; Newman MF
    Anesth Analg; 2000 Nov; 91(5):1085-90. PubMed ID: 11049888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-benefit and efficacy of aprotinin compared with epsilon-aminocaproic acid in patients having repeated cardiac operations: a randomized, blinded clinical trial.
    Bennett-Guerrero E; Sorohan JG; Gurevich ML; Kazanjian PE; Levy RR; Barberá AV; White WD; Slaughter TF; Sladen RN; Smith PK; Newman MF
    Anesthesiology; 1997 Dec; 87(6):1373-80. PubMed ID: 9416723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perioperative renal outcome in cardiac surgical patients with preoperative renal dysfunction: aprotinin versus epsilon aminocaproic acid.
    Maslow AD; Chaudrey A; Bert A; Schwartz C; Singh A
    J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):6-15. PubMed ID: 18249324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can epsilon-aminocaproic acid balance the off-pump bleeding advantage?
    Stassano P; Musumeci A; Santise G; Gagliardi C; Montalto A; Spampinato N
    Cardiovasc Surg; 2003 Jun; 11(3):219-23. PubMed ID: 12704332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mortality associated with aprotinin during 5 years following coronary artery bypass graft surgery.
    Mangano DT; Miao Y; Vuylsteke A; Tudor IC; Juneja R; Filipescu D; Hoeft A; Fontes ML; Hillel Z; Ott E; Titov T; Dietzel C; Levin J; ;
    JAMA; 2007 Feb; 297(5):471-9. PubMed ID: 17284697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aprotinin but not epsilon-aminocaproic acid decreases interleukin-10 after cardiac surgery with extracorporeal circulation: randomized, double-blind, placebo-controlled study in patients receiving aprotinin and epsilon-aminocaproic acid.
    Greilich PE; Okada K; Latham P; Kumar RR; Jessen ME
    Circulation; 2001 Sep; 104(12 Suppl 1):I265-9. PubMed ID: 11568067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epsilon aminocaproic acid and the control of post-prostatectomy bleeding: a prospective double-blind study.
    Smith RB; Riach P; Kaufman JJ
    J Urol; 1984 Jun; 131(6):1093-5. PubMed ID: 6539381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of epsilon-aminocaproic acid in reducing bleeding after cardiac operation: a double-blind randomized study.
    Vander Salm TJ; Ansell JE; Okike ON; Marsicano TH; Lew R; Stephenson WP; Rooney K
    J Thorac Cardiovasc Surg; 1988 Mar; 95(3):538-40. PubMed ID: 3278170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening carotid ultrasonography and risk factors for stroke in coronary artery surgery patients.
    D'Agostino RS; Svensson LG; Neumann DJ; Balkhy HH; Williamson WA; Shahian DM
    Ann Thorac Surg; 1996 Dec; 62(6):1714-23. PubMed ID: 8957376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epsilon-aminocaproic acid for treatment of fibrinolysis during liver transplantation.
    Kang Y; Lewis JH; Navalgund A; Russell MW; Bontempo FA; Niren LS; Starzl TE
    Anesthesiology; 1987 Jun; 66(6):766-73. PubMed ID: 3296855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of ε-Aminocaproic Acid-Induced Massive Thromboemboli Using Tissue Plasminogen Activator During Cardiac Surgery: A Case Report.
    Roy KM; Rajan GR
    A A Pract; 2019 May; 12(10):372-374. PubMed ID: 30550436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aprotinin during coronary-artery bypass grafting and risk of death.
    Schneeweiss S; Seeger JD; Landon J; Walker AM
    N Engl J Med; 2008 Feb; 358(8):771-83. PubMed ID: 18287600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized trial of the topical effect of antifibrinolytic epsilon aminocaproic Acid on coronary artery bypass surgery without cardiopulmonary bypass.
    Gurian DB; Meneghini A; Abreu LC; Murad N; Matos LL; Pires AC; Valenti VE; Breda JR
    Clin Appl Thromb Hemost; 2014 Sep; 20(6):615-20. PubMed ID: 23434921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.